Cargando…
The impact of Covid-19 in patients with chronic myeloid leukemia—a nationwide population-based study
Autores principales: | Dahlén, Torsten, Flygt, Hjalmar, Lübking, Anna, Olsson-Strömberg, Ulla, Wennström, Lovisa, Dreimane, Arta, Själander, Anders, Leach, Susannah, Gisslén, Magnus, Li, Huiqi, Höglund, Martin, Stenke, Leif, Nyberg, Fredrik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088575/ https://www.ncbi.nlm.nih.gov/pubmed/37037908 http://dx.doi.org/10.1038/s41375-023-01893-1 |
Ejemplares similares
-
Adverse outcomes in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: Follow‐up of patients diagnosed 2002–2017 in a complete coverage and nationwide agnostic register study
por: Dahlén, Torsten, et al.
Publicado: (2022) -
A comprehensive characterization of patients diagnosed with post-COVID-19 condition in Sweden 16 months after the introduction of the International Classification of Diseases Tenth Revision diagnosis code (U09.9): a population-based cohort study
por: Bygdell, Maria, et al.
Publicado: (2023) -
Covid-19 vaccine effectiveness against post-covid-19 condition among 589 722 individuals in Sweden: population based cohort study
por: Lundberg-Morris, Lisa, et al.
Publicado: (2023) -
The social patterning of Covid-19 vaccine uptake in older adults: A register-based cross-sectional study in Sweden
por: Spetz, Malin, et al.
Publicado: (2022) -
IFN-α with dasatinib broadens the immune repertoire in patients with chronic-phase chronic myeloid leukemia
por: Huuhtanen, Jani, et al.
Publicado: (2022)